These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16968570)

  • 41. Drug evaluation: CNTO-1275, a mAb against IL-12/IL-23p40 for the potential treatment of inflammatory diseases.
    Wittig BM
    Curr Opin Investig Drugs; 2007 Nov; 8(11):947-54. PubMed ID: 17979029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial.
    van Oosten BW; Lai M; Hodgkinson S; Barkhof F; Miller DH; Moseley IF; Thompson AJ; Rudge P; McDougall A; McLeod JG; Adèr HJ; Polman CH
    Neurology; 1997 Aug; 49(2):351-7. PubMed ID: 9270561
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetic/pharmacodynamic models for the depletion of Vbeta5.2/5.3 T cells by the monoclonal antibody ATM-027 in patients with multiple sclerosis, as measured by FACS.
    Zingmark PH; Edenius C; Karlsson MO
    Br J Clin Pharmacol; 2004 Oct; 58(4):378-89. PubMed ID: 15373930
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis.
    Constantinescu CS; Asher A; Fryze W; Kozubski W; Wagner F; Aram J; Tanasescu R; Korolkiewicz RP; Dirnberger-Hertweck M; Steidl S; Libretto SE; Sprenger T; Radue EW
    Neurol Neuroimmunol Neuroinflamm; 2015 Aug; 2(4):e117. PubMed ID: 26185773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase 1 Evaluation of Elezanumab (Anti-Repulsive Guidance Molecule A Monoclonal Antibody) in Healthy and Multiple Sclerosis Participants.
    Kalluri HV; Rosebraugh MR; Misko TP; Ziemann A; Liu W; Cree BAC
    Ann Neurol; 2023 Feb; 93(2):285-296. PubMed ID: 36093738
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biological agents: new drugs, old problems.
    Muñoz-Cano R; Carnés J; Sanchez-Lopez J; Saiz A; Bartra J; Lopez-Matas MA; Picado C; Valero A
    J Allergy Clin Immunol; 2010 Aug; 126(2):394-5. PubMed ID: 20579714
    [No Abstract]   [Full Text] [Related]  

  • 47. A Phase 1 Randomized Dose-Escalation Study of a Human Monoclonal Antibody to IL-6 in CKD.
    Nowak KL; Kakkar R; Devalaraja M; Lo L; Park W; Gobburu J; Kling D; Davidson M; Chonchol M
    Kidney360; 2021 Feb; 2(2):224-235. PubMed ID: 35373026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cutaneous infarction under IL-12/23 p40 inhibition: a cautionary note.
    Lipsker D; Lutz V
    Arch Dermatol; 2011 Nov; 147(11):1344-5. PubMed ID: 22106139
    [No Abstract]   [Full Text] [Related]  

  • 49. Targeting cytokine networks in neuroinflammatory diseases.
    Becher B; Derfuss T; Liblau R
    Nat Rev Drug Discov; 2024 Sep; ():. PubMed ID: 39261632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ustekinumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk, and infant serum.
    Saito J; Kaneko K; Kawasaki H; Hayakawa T; Yakuwa N; Suzuki T; Sago H; Yamatani A; Murashima A
    J Pharm Health Care Sci; 2022 Jul; 8(1):18. PubMed ID: 35773736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated Serum Interleukin-23 Levels in Patients with Oral and Cutaneous Lichen Planus.
    Mardani M; Mofidi H; Dastgheib L; Ranjbar S; Hamidizadeh N
    Mediators Inflamm; 2021; 2021():5578568. PubMed ID: 34335090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis.
    Wootla B; Watzlawik JO; Stavropoulos N; Wittenberg NJ; Dasari H; Abdelrahim MA; Henley JR; Oh SH; Warrington AE; Rodriguez M
    Expert Opin Biol Ther; 2016 Jun; 16(6):827-839. PubMed ID: 26914737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications.
    Bittner S; Wiendl H
    Neurotherapeutics; 2016 Jan; 13(1):4-19. PubMed ID: 26563391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases.
    Tabarkiewicz J; Pogoda K; Karczmarczyk A; Pozarowski P; Giannopoulos K
    Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):435-49. PubMed ID: 26062902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis.
    Xie ZX; Zhang HL; Wu XJ; Zhu J; Ma DH; Jin T
    Mediators Inflamm; 2015; 2015():513295. PubMed ID: 25705093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High affinity humanized antibodies without making hybridomas; immunization paired with mammalian cell display and in vitro somatic hypermutation.
    McConnell AD; Do M; Neben TY; Spasojevic V; MacLaren J; Chen AP; Altobell L; Macomber JL; Berkebile AD; Horlick RA; Bowers PM; King DJ
    PLoS One; 2012; 7(11):e49458. PubMed ID: 23166676
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis.
    Gensicke H; Leppert D; Yaldizli Ö; Lindberg RL; Mehling M; Kappos L; Kuhle J
    CNS Drugs; 2012 Jan; 26(1):11-37. PubMed ID: 22171583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin-23: as a drug target for autoimmune inflammatory diseases.
    Tang C; Chen S; Qian H; Huang W
    Immunology; 2012 Feb; 135(2):112-24. PubMed ID: 22044352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDS.
    Yannam GR; Gutti T; Poluektova LY
    J Neuroimmune Pharmacol; 2012 Mar; 7(1):95-112. PubMed ID: 21947740
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab.
    Benson JM; Sachs CW; Treacy G; Zhou H; Pendley CE; Brodmerkel CM; Shankar G; Mascelli MA
    Nat Biotechnol; 2011 Jul; 29(7):615-24. PubMed ID: 21747388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.